Rhumbline Advisers Valneva Se Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Valneva Se stock. As of the latest transaction made, Rhumbline Advisers holds 51 shares of VALN stock, worth $562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 174
70.69%
Holding current value
$562
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VALN
# of Institutions
20Shares Held
4.52MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.38MShares$26.2 Million1.17% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.46MShares$16.1 Million0.44% of portfolio
-
General American Investors CO Inc354KShares$3.91 Million0.14% of portfolio
-
Wells Fargo & Company San Francisco, CA245KShares$2.7 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il35.7KShares$394,1900.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $762M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...